MedPath

Monocentric randomised prospective intraindividuel parallel group comparison study to calculate HbA1c of self monitored blood glucose values of the last days and to use blood glucose documentation in a specialized diary with biofeedback system.

Not Applicable
Recruiting
Conditions
E10.90
E11.90
Registration Number
DRKS00004339
Lead Sponsor
Praxis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

•Insulin treated patients with diabetes, who have to measure blood glucose at least four times daily (intensified conventionel therapy).
•Insulin treatment at least 6 months.
•age over 18 years
•signed and dated consent

Exclusion Criteria

•reported ketoacidosis in the last 3 months
•reported severe hypoglycemic episode in the last 3 months
•Pregnancy
•patients, who seem unable to follow protokol
•hemoglobin < 11g/dl
•6% < HbA1c > 11%
•patients, who can not legaly sign consent

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
with hemocue (point of care test) measured HbA1c after 3 and 6 months
Secondary Outcome Measures
NameTimeMethod
from glucose monitoring system analysed Hypoglycemia, blood glucose variability, calculated HbA1c
© Copyright 2025. All Rights Reserved by MedPath